CDK1 and cancer: Wee1 exerts its regulatory role by binding cyclin-dependent kinase (Cdk1) and limiting its mitosis-initiating activity in response to DNA damage; as such, it is an effector upon which different transduction pathways converge in response to DNA damage, and a preferred therapeutic target for a variety of cancers [131].